5TrottiA, ColevasAD, SetserA, etal. CTCAEv3.0: develop- ment of a comprehensive grading system for the adverse effects of cancer treatmen[J].Semin Radiat Oncol, 2003, 13(3): 178-181.
6OkamotoT,Fukada, AndoT, et al.Evalnation of a combination chemotherapy with nedaplat in and 5-Fu for oral cance[J].Gan To Kagkn ryoho, 1996,23: 79.
7Gebbia V, Galetta D, Caruso M, et al. Gruppo Ocologico It- ailia Meridionale. Gem citabine and cisplantin versus vi- norelbine and cisplatin vesus ifosfamide-gemcita-bine fol- lowed by vinorelbine and cispatin versus vinorelbine and cisplatinfollowed by ifosfamide and gemcitabine in .:tage 1 m B-IV non small cell lung carcinoma: a prospective ran- domized phase I: trial of the Gruppo Oncologico Italia Me- ridionale [ J ]. Lnng Cancer,2003,39 (2) : 179.
8Yang L, Parkin DM, Li L, et al. Estimates of cancer inci- dence in China for 2000 and projeetions for 2005 [ J ]. Cancer Epidemiol Biomarkers Prey,2005,14( 1 ) :243.
